C
Kiniksa Pharmaceuticals International, plc KNSA
$31.98 $1.725.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 156.80M 137.79M 122.54M 112.21M 108.63M
Total Other Revenue -- -- -- -- --
Total Revenue 156.80M 137.79M 122.54M 112.21M 108.63M
Cost of Revenue 71.02M 61.66M 66.09M 49.42M 42.34M
Gross Profit 85.78M 76.13M 56.45M 62.80M 66.30M
SG&A Expenses 46.86M 43.53M 40.54M 46.40M 42.40M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 136.64M 124.51M 141.84M 121.87M 108.75M
Operating Income 20.16M 13.27M -19.30M -9.66M -117.00K
Income Before Tax 22.88M 15.57M -16.98M -7.20M 2.30M
Income Tax Expenses 5.05M 7.03M -8.09M 5.49M 6.21M
Earnings from Continuing Operations 17.83M 8.54M -8.89M -12.69M -3.91M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 17.83M 8.54M -8.89M -12.69M -3.91M
EBIT 20.16M 13.27M -19.30M -9.66M -117.00K
EBITDA 20.52M 13.62M -18.90M -9.26M 313.00K
EPS Basic 0.24 0.12 -0.12 -0.18 -0.06
Normalized Basic EPS 0.19 0.13 -0.15 -0.06 0.02
EPS Diluted 0.23 0.11 -0.12 -0.18 -0.06
Normalized Diluted EPS 0.18 0.13 -0.15 -0.06 0.02
Average Basic Shares Outstanding 73.44M 72.65M 72.32M 71.73M 71.00M
Average Diluted Shares Outstanding 77.94M 76.15M 72.32M 71.73M 71.00M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --